BiotechTube
ThermaSolutions

ThermaSolutions

San Diego, United States· Est.
thermasolutions.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ThermaSolutions is a long-established, private medical device company focused on localized hyperthermic chemotherapy delivery systems for surgical oncology. Its flagship ThermoChem HT devices circulate heated chemotherapy perfusate in the abdominal cavity (HIPEC), while its HurriChem system enables aerosolized delivery for laparoscopic procedures (PIPAC). The company has a commercial portfolio with FDA and CE-marked products, positions itself as the international leader in HIPEC technology, and is expanding into whole-body hyperthermia through a partnership. Its business model revolves around selling capital equipment and proprietary single-use disposable procedure kits.

OncologyPeritoneal Surface Malignancies

Technology Platform

Hyperthermic drug delivery platforms for localized (HIPEC), aerosolized/regional (PIPAC), and systemic (whole-body) chemotherapy enhancement.

Opportunities

Expansion of the PIPAC procedure for peritoneal cancers represents a significant near-term growth driver, especially if U.S.
FDA approval for the chemotherapy indication is secured.
The partnership for whole-body hyperthermia opens an adjacent market in late-stage oncology care.
Growing global recognition and standardization of HIPEC procedures continues to drive core business growth.

Risk Factors

Growth is dependent on the adoption rate of complex surgical procedures (HIPEC/PIPAC) which are limited to specialized centers.
Regulatory uncertainty, particularly for the HurriChem PIPAC indication in the U.S., poses a hurdle.
The company faces competition from other medical device makers and must continuously demonstrate the clinical and economic value of its proprietary systems and disposables.

Competitive Landscape

ThermaSolutions competes in the specialized market of hyperthermic perfusion systems. It faces competition from other companies offering HIPEC equipment (e.g., Belmont, Gamida) and from hospitals using manual or generic pump systems. In the emerging PIPAC space, it is an early mover but may face competition from other nebulizer/irrigation device manufacturers and potential new entrants as the procedure gains validation.

More companies in Oncology (General) →More companies in United States →